Eosinophil Mechanisms of Sensory Neuroplasticity in a Murine Model of Asthma
Eosinophil Mechanisms of Sensory Neuroplasticity in a Murine Model of Asthma
批准号:
8685774
负责人:
Gregory David Scott
金额:
$4.77万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-30 至 2015-06-29
关键词:
Afferent NeuronsAgeAgonistAsthmaBlocking AntibodiesBrain-Derived Neurotrophic FactorBreedingBronchoconstrictionC57BL/6 MouseCellsChronicCoculture TechniquesComputersConfocal MicroscopyCoughingDataDiphtheria ToxinDiseaseDissectionDrug or chemical Tissue DistributionEnvironmental air flowEpithelialExhibitsFunctional disorderGoalsGrowthHealthHypersensitivityIL5 geneImageImage AnalysisImageryImaging TechniquesImpairmentIn VitroIndividualInflammatoryInterleukin-5LengthLungLung diseasesMeasuresMechanical ventilationMediatingMethodsModelingMolecularMusNTF3 geneNerveNeuritesNeuronal PlasticityNeuronsOperative Surgical ProceduresOvalbuminPathogenesisPathologicPharmaceutical PreparationsReflex actionResearchResistanceRiskRoleSensorySensory GangliaSerotoninSerotonin AgonistsShortness of BreathSignal TransductionStructureSystemTechniquesTestingThree-Dimensional ImageTransgenic MiceTransgenic OrganismsVagotomyWorkaerosolizedafferent nerveairway hyperresponsivenesscomputerizeddensityeosinophileosinophil peroxidasefollow-upin vivoinsightmouse modelnerve supplyneurotrophic factorneurotrophin 4neutralizing antibodynew therapeutic targetnovelpromoterpublic health relevancereconstructionresearch studyresponsesensory mechanismtherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease of the lung and a significant health burden. Although appropriate usage of asthma medications successfully reduces impairment they do not slow progression and potentially increase risk of exacerbation. Asthma is also a heterogenous disease with various pathologic features and treatment-resistant subtypes. The following project aims to offer insight into sensory neuroplasticity, or how sensory neurons change in asthma, which is an established therapeutic target and useful tool to characterize asthma subtypes. Airway sensory neurons in asthma malfunction and cause airway hyperreactivity. The upstream changes to neuron structure and inciting factor behind sensory dysfunction are unknown due to obstacles in characterizing airway innervation. For the current project a novel method was developed permitting the visualization of whole airway innervation and computerized quantification of nerve branching and nerve density. We have shown that increased eosinophils in the airway results in a doubling of nerve branchpoints and length. The long term goal of this research is to use this technique in tandem with transgenic, in vitro, and molecular approaches to characterize and understand asthma-related sensory neuroplasticity. Guided by data from similar diseases and preliminary data, the current project will test if sensory neuron branching and density increases via eosinophils in two asthma models and if branched outgrowth correlates with increased sensory nerve-induced reflex bronchoconstriction. Preliminary data has already demonstrated some of these changes. This project will subsequently investigate the role of eosinophil-derived neurotrophins in producing asthma-related sensory neuroplasticity. The current project will use several mouse models of asthma including 1.) an valbumin sensitization and challenge model, 2.) transgenic mice lacking eosinophils, and 3.) transgenic mice exhibiting overabundant lung eosinophils. For the first aim, airway nerve branching and length will be quantified with computational nerve modeling and compared to a functional readout, that of reflex bronchoconstriction. The second aim is to investigate the role of eosinophil neurotrophin (NGF, BDNF, NT-3, NT-4) release on sensory neuroplasticity using a co-culture system. Eosinophil and sensory neuron co-cultures will be used with exogenous administration of neurotrophins, and neurotrophin blocking antibodies followed by quantification of neuron branched outgrowth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early pathogenesis and diagnosis of Parkinsons Disease in peripheral tissues
-
批准号:10486334
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Gregory David Scott
-
依托单位:
Eosinophil Mechanisms of Sensory Neuroplasticity in a Murine Model of Asthma
-
批准号:8253572
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2013
-
负责人:Gregory David Scott
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: